Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07516132 · ClinicalTrials.gov registry record · Phase 3
Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study
A Phase 3 study, sponsored by Ocular Therapeutix.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 850
- Enrollment target
NCT07516132: Recruiting Phase 3 study, sponsored by Ocular Therapeutix.
NCT07516132 is a Phase 3 study that is actively recruiting participants, run by Ocular Therapeutix. The registered enrollment target is 850 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (10% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07516132, a Phase 3 study, is actively recruiting participants, sponsored by Ocular Therapeutix.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 850 participants
- Enrollment target
Study Summary
Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants with Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study
Primary Outcome
Number of events
Interventions
- DRUG OTX-TKI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 850 participants |
| Start Date | 2026-04-27 |
| Est. Completion | 2030-08-01 |
| Phase | Phase 3 |
What NCT07516132 shows while recruiting
NCT07516132 is an interventional study that assigns participants to a tested intervention. The registered 850 participants enrollment target is mid-sized for trials with a published cap, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (10% higher).
The record links to 0 conditions, and to 1 intervention - of which OTX-TKI is the first listed.
NCT07516132 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07516132 about?
NCT07516132 is a clinical study titled "Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study". Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants with Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study
What is the current status of trial NCT07516132?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 850 participants. The study started on 2026-04-27. Estimated completion is 2030-08-01.
What interventions are being tested in trial NCT07516132?
The interventions under investigation include: OTX-TKI (DRUG).
Who is sponsoring clinical trial NCT07516132?
This trial is sponsored by Ocular Therapeutix, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07516132's enrollment target sits among peer trials
850 387th of 2000 higher than 1,612 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03507257 · 850 participants
Longitudinal Early-onset Alzheimer's Disease Study Protocol
- NCT05846841 · 850 participants · NA
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
- NCT05987059 · 850 participants · Phase 2
Involving Communities in Addressing the Maternal Health Crisis: Making an IMPACT
- NCT06289673 · 850 participants · Phase 4
Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI